Analytical and clinical validation of a novel in-house deep-sequencing method for minimal residual disease monitoring in a phase II trial for multiple myelomaJoaquín Martínez‐López, Joan Bargay, J Bladé et al.|Leukemia|2017Cited by 51
A novel deep targeted sequencing method for minimal residual disease monitoring in acute myeloid leukemiaEsther Onecha, Rosa Ayala, María Linares et al.|Haematologica|2018Cited by 51
Real-life disease monitoring in follicular lymphoma patients using liquid biopsy ultra-deep sequencing and PET/CTAna Jiménez Ubieto, Santiago Barrio, María Poza et al.|Leukemia|2023Cited by 40
A novel targeted RNA-Seq panel identifies a subset of adult patients with acute lymphoblastic leukemia with BCR-ABL1-like characteristicsRicardo Sánchez, Joaquín Martínez‐López, Jordi Ribera et al.|Blood Cancer Journal|2020Cited by 23
NGS-Based Molecular Karyotyping of Multiple Myeloma: Results from the GEM12 Clinical TrialJuan Manuel Rosa-Rosa, Joaquín Martínez‐López, Isabel Cuenca et al.|Cancers|2022Cited by 15